Cingulate Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring at the Cingulate Inc. 2026 Annual Meeting of Stockholders held on July 9, 2026. The filing details corporate governance changes, equity plan amendments, and the results of stockholder votes.
Key Financial Metrics
This filing is a current report regarding corporate events and does not contain financial statements. Consequently, data regarding revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes and Corporate Actions
- Equity Plan Amendment: Stockholders approved Amendment No. 3 to the 2021 Omnibus Equity Incentive Plan, increasing the authorized share count by 625,000 shares, bringing the total to 2,221,126 shares.
- Board Restructuring: The Board of Directors reduced its size to five (5) directors.
- Leadership Appointments:
- Shane Schaffer (CEO) appointed Chairman of the Board.
- Jeff Hargroves appointed Lead Independent Director.
- Zhanpeng "Frederick" Jiang appointed Chairman of the Audit Committee.
- Jeff Hargroves appointed Chairman of the Nominating and Corporate Governance Committee.
- Bryan Lawrence appointed Chairman of the Compensation Committee.
Voting Results and Outlook
Four proposals were submitted to stockholders. All proposals received sufficient votes for approval, rendering the adjournment proposal unnecessary.
| Proposal | For | Against | Abstain | Result |
|---|---|---|---|---|
| Election of Jeff Hargroves (Class II Director) | 3,563,369 | 40,558 | 4,672,130 (Broker Non-Votes) | Approved |
| Ratification of KPMG LLP (Auditor) | 8,153,858 | 100,881 | 21,318 | Approved |
| Equity Plan Amendment | 3,196,215 | 372,123 | 35,589 | Approved |
| Adjournment of Meeting | 7,563,297 | 663,663 | 49,097 | Approved (Not Necessary) |
Management Commentary: The filing notes that the Equity Plan Amendment became effective immediately upon stockholder approval. No specific forward-looking guidance or risk factors were disclosed in this specific report beyond standard corporate governance updates.
Investor Verification Checklist
- Verify the impact of the 625,000 share increase on potential dilution for existing shareholders.
- Review the full text of Exhibit 10.1 (Amendment No. 3) for specific terms regarding vesting and eligibility.
- Confirm the new committee compositions to assess independence and oversight capabilities.
- Check subsequent filings for the company's next quarterly or annual financial results, as this 8-K contains no financial data.